Compound Detail
CHEMBL29609
PLECONARIL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL29609 |
| Name | PLECONARIL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | KQOXLKOJHVFTRN-UHFFFAOYSA-N |
38
Targets
92
Activities
2
Assay Types
11
PK Parameters
20
Publications
8
Known Names
3
Indications
1
Mechanisms
Molecular Properties
381.4
MW (Da)
4.68
ALogP
6
HBA
0
HBD
74.2
PSA (Ų)
0.58
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| VP1 capsid protein disrupting agent | DISRUPTING AGENT | VP1 capsid protein | ✓ | ✓ |
Indications
Diabetes Mellitus, Type 1 Enterovirus Infections Virus Diseases
ATC Classification
J05AX06
pleconaril
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE
Activity Summary
EC50 78 meas. best 8.7
IC50 14 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Coxsackievirus B3 CHEMBL613554 | IC50 | 9.0 | 7.0857 | 1.0 | 7 |
| Coxsackievirus B3 CHEMBL613554 | EC50 | 8.7 | 6.795 | 2.0 | 2 |
| VP1 capsid protein CHEMBL3833484 | EC50 | 8.4 | 7.5157 | 4.0 | 7 |
| Coxsackievirus B5 CHEMBL613555 | EC50 | 8.3 | 8.2333 | 5.0 | 3 |
| Unchecked CHEMBL612545 | EC50 | 8.3 | 7.7283 | 5.0 | 6 |
| rhinovirus A2 CHEMBL612678 | EC50 | 8.15 | 7.55 | 7.0 | 3 |
| rhinovirus A29 CHEMBL612403 | EC50 | 7.58 | 7.58 | 26.0 | 1 |
| Coxsackievirus A9 CHEMBL615086 | EC50 | 7.48 | 7.48 | 33.0 | 1 |
| rhinovirus A2 CHEMBL612678 | IC50 | 7.4 | 7.4 | 40.0 | 1 |
| rhinovirus A39 CHEMBL612527 | EC50 | 7.36 | 7.18 | 44.0 | 2 |
| Human rhinovirus A protease CHEMBL2857 | EC50 | 7.24 | 7.24 | 58.0 | 1 |
| rhinovirus B14 CHEMBL613759 | IC50 | 7.16 | 7.16 | 70.0 | 1 |
| rhinovirus A21 CHEMBL612371 | EC50 | 7.14 | 7.004 | 73.0 | 5 |
| rhinovirus B14 CHEMBL613759 | EC50 | 7.12 | 6.518 | 75.0 | 10 |
| rhinovirus A89 CHEMBL613756 | EC50 | 7.12 | 7.12 | 75.0 | 1 |
| rhinovirus A9 CHEMBL612473 | EC50 | 7.08 | 7.08 | 83.0 | 1 |
| Poliovirus 3 CHEMBL613557 | EC50 | 7.08 | 6.4067 | 84.0 | 3 |
| rhinovirus A63 CHEMBL612478 | EC50 | 7.07 | 7.07 | 85.0 | 1 |
| rhinovirus B86 CHEMBL612480 | EC50 | 7.05 | 6.795 | 89.0 | 2 |
| Coxsackievirus B1 CHEMBL612677 | EC50 | 6.89 | 6.89 | 130.0 | 1 |
| Enterovirus CHEMBL613749 | EC50 | 6.87 | 6.87 | 136.0 | 1 |
| rhinovirus A15 CHEMBL612525 | EC50 | 6.78 | 6.78 | 166.0 | 1 |
| Rhinovirus B CHEMBL612466 | EC50 | 6.7 | 6.275 | 200.0 | 2 |
| Human rhinovirus sp. CHEMBL612470 | IC50 | 6.7 | 6.53 | 200.0 | 2 |
| rhinovirus A1B CHEMBL613713 | EC50 | 6.62 | 6.62 | 240.0 | 1 |
| enterovirus D68 CHEMBL613204 | EC50 | 6.62 | 6.42 | 240.0 | 5 |
| Nuclear receptor subfamily 1 group I member 2 CHEMBL3401 | EC50 | 6.6 | 6.6 | 251.2 | 1 |
| rhinovirus A16 CHEMBL613769 | EC50 | 6.57 | 6.39 | 270.0 | 4 |
| rhinovirus A59 CHEMBL612477 | EC50 | 6.33 | 6.33 | 471.0 | 1 |
| rhinovirus B70 CHEMBL612479 | EC50 | 6.24 | 6.24 | 578.0 | 1 |
| rhinovirus A41 CHEMBL612476 | EC50 | 6.18 | 6.18 | 655.0 | 1 |
| rhinovirus A85 CHEMBL612529 | EC50 | 6.05 | 6.05 | 883.0 | 1 |
| rhinovirus A16 CHEMBL613769 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Poliovirus 2 CHEMBL613752 | EC50 | 5.96 | 5.96 | 1084.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 5.9 | 5.9 | 1258.9 | 1 |
| rhinovirus B72 CHEMBL612549 | EC50 | 5.75 | 5.75 | 1800.0 | 1 |
| Poliovirus 1 CHEMBL613556 | EC50 | 5.7 | 5.16 | 2000.0 | 2 |
| Enterovirus C CHEMBL612462 | EC50 | 5.66 | 5.615 | 2200.0 | 2 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.2 | 5.2 | 6309.6 | 1 |
| rhinovirus A45 CHEMBL612464 | EC50 | 5.05 | 5.05 | 8900.0 | 1 |
| Enterovirus A71 CHEMBL612436 | EC50 | 4.87 | 4.87 | 13400.0 | 1 |
| Molecular identity unknown CHEMBL612546 | EC50 | 4.0 | 4.0 | 100000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 11753.0 | ng.hr.mL-1 | Canis lupus familiaris |
| CL | 12.83 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 22.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 20.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 13.49 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 14.45 | mL.min-1.g-1 | Homo sapiens |
| Fu | 0.0013 | - | Homo sapiens |
| Fu | 0.002 | - | Rattus norvegicus |
| T1/2 | 2.5 | hr | Simiiformes |
| T1/2 | 27.0 | hr | Canis lupus familiaris |
| t1/2 | - | - | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine